mRNA |
ciclosporin |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.003 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.003 |
mRNA |
STF-31 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.004 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.098 |
0.004 |
mRNA |
isonicotinohydroxamic acid |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.005 |
mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.005 |
mRNA |
SMER-3 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.005 |
mRNA |
Oxaliplatin |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.005 |
mRNA |
Bax channel blocker |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.005 |
mRNA |
BRD-A94377914 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.005 |